Diligence memo · auto-generated · as of July 2, 2026
Analyte Health, Inc.
Analyte Health, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Analyte Health, Inc. operates in Healthtech, based in CHICAGO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Analyte Health, Inc. has raised $22M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $27M on 2017-09-05.
Most recent recorded round closed around 2017-09-05.
Valuation (modeled)modeled
Provath models Analyte Health, Inc. at approximately $68M (range $3.8M–$369M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.51× the median modeled value of Series A Healthtech companies in 2016–2018 (103 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 18 months.
Last raise 8.8 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 8.9× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 81% of Healthtech peers (2138 compared).
Modeled value ranks above 69% of those peers.
Closest niche peers: Prenexus Health, LLC, HealthMyne, Inc., Companion Medical, Inc., Health at Scale Corp, Motus GI Medical Technologies, Ltd..
Peoplefiled
12 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.